Pseudo-resistance to anticancer drugs

Pseudo-resistance to anticancer drugs

Bibliographic Details
Main Authors:	Enrico Davoli, Massimo Zucchetti, Raffaella Giavazzi, Silvio Garattini, Roberta Frapolli
Format:	Article
Language:	English
Published:	SAGE Publishing 2022-11-01
Series:	Therapeutic Advances in Medical Oncology
Online Access:	https://doi.org/10.1177/17588359221136776

Similar Items

Determination of paclitaxel distribution in solid tumors by nano-particle assisted laser desorption ionization mass spectrometry imaging.
by: Lavinia Morosi, et al.
Published: (2013-01-01)

More research is needed for generic drugs
by: Silvio Garattini
Published: (2012-10-01)

Tumor delivery of chemotherapy combined with inhibitors of angiogenesis and vascular targeting agents
by: Marta eCesca, et al.
Published: (2013-10-01)

Pharmacokinetic Characterization of the DDAH1 Inhibitors ZST316 and ZST152 in Mice Using a HPLC-MS/MS Method
by: Arduino A. Mangoni, et al.
Published: (2022-02-01)

Therapy of epilepsy: analysis of pseudo-drug resistance
by: N. V. Yegorova, et al.
Published: (2008-12-01)

Resistance and Pseudo-resistance to permethrin: the importance of controlling scabies
by: Fabio Rinaldi, et al.
Published: (2023-11-01)

Predicting Anticancer Drug Resistance Mediated by Mutations
by: Yu-Feng Lin, et al.
Published: (2022-01-01)

Common themes in antimicrobial and anticancer drug resistance
by: Mariana Carmen Chifiriuc, et al.
Published: (2022-08-01)

Mitophagy in carcinogenesis, drug resistance and anticancer therapeutics
by: Yanjie Guan, et al.
Published: (2021-07-01)

Hybrid Drugs—A Strategy for Overcoming Anticancer Drug Resistance?
by: Marta Szumilak, et al.
Published: (2021-04-01)

Resistance or pseudo-resistance?
by: R. Zanardi, et al.
Published: (2022-06-01)

The Effects of Vandetanib on Paclitaxel Tumor Distribution and Antitumor Activity in a Xenograft Model of Human Ovarian Carcinoma
by: Marta Cesca, et al.
Published: (2009-11-01)

PEGylated recombinant human hyaluronidase (PEGPH20) pre-treatment improves intra-tumour distribution and efficacy of paclitaxel in preclinical models
by: Lavinia Morosi, et al.
Published: (2021-09-01)

Pharmaceutical Strategy for Europe: Reflections on Public Health-Driven Drug Development, Regulation, and Policies
by: Silvio Garattini, et al.
Published: (2021-04-01)

Extracellular Vesicles and Resistance to Anticancer Drugs: A Tumor Skeleton Key for Unhinging Chemotherapies
by: Simona Pompili, et al.
Published: (2022-06-01)

Combination therapy in cancer: effects of angiogenesis inhibitors on drug pharmacokinetics and pharmacodynamics
by: Ilaria Fuso Nerini, et al.
Published: (2016-06-01)

Development of a HPLC-MS/MS Method to Assess the Pharmacokinetics and Tumour Distribution of the Dimethylarginine Dimethylaminohydrolase 1 Inhibitors ZST316 and L-257 in a Xenograft Model of Triple-Negative Breast Cancer in Mice
by: Tommaso Ceruti, et al.
Published: (2023-12-01)

Displaced vertices from pseudo-Dirac dark matter
by: Alessandro Davoli, et al.
Published: (2017-11-01)

Cancer cells acquire resistance to anticancer drugs: An update
by: Hsing-Pang Lu, et al.
Published: (2012-12-01)

Corrigendum: Resistance and pseudo-resistance to permethrin phenomena: the importance of controlling scabies
by: Fabio Rinaldi, et al.
Published: (2024-01-01)

Pseudo-peptides in drug discovery /
by: Nielsen, Peter E., 1951-
Published: (2004)

Caffeine, coffee, and health /
by: Garattini, Silvio
Published: (1993)

Editorial: Managing cancer metastasis by tackling anticancer drug resistance
by: Erxi Wu, et al.
Published: (2024-06-01)

Non-Coding RNAs and Resistance to Anticancer Drugs in Gastrointestinal Tumors
by: Jens C. Hahne, et al.
Published: (2018-06-01)

Cardiotoxicity of Anticancer Drugs
by: I. Maiborodin, et al.
Published: (2025-02-01)

CircRNAs in anticancer drug resistance: recent advances and future potential
by: Tianwei Xu, et al.
Published: (2020-08-01)

Systematic identification of signaling pathways with potential to confer anticancer drug resistance
by: Martz, C. A., et al.
Published: (2015)

Two Different Responsive Organosilica Nanocarriers to Combine Chemo- and Immunotherapy against Cancer
by: Maria Sancho-Albero, et al.
Published: (2024-09-01)

Anticancer effects of olive oil polyphenols and their combinations with anticancer drugs
by: Torić Jelena, et al.
Published: (2019-12-01)

Tomographic pseudo-inversion of resistivity profiles
by: D. Luzio, et al.
Published: (1997-06-01)

Sustainability in anticancer drugs development
by: Chaudhary Arpna, et al.
Published: (2024-01-01)

Advances in Anticancer Drug Discovery
by: Jóhannes Reynisson
Published: (2021-03-01)

Anticancer Platinum Drugs Update
by: Giuliano Ciarimboli
Published: (2021-11-01)

Piperine: An Anticancer and Senostatic Drug
by: Jae Sung Lim, et al.
Published: (2022-04-01)

Special Issue “Anticancer Drugs”
by: Mary J. Meegan, et al.
Published: (2019-09-01)

Pricing in the Market for Anticancer Drugs
by: Howard, David H., et al.
Published: (2015)

Medicinal chemistry of anticancer drugs /
by: 172264 Avendano, Carmen, et al.
Published: (2008)

Liposomal Drug Delivery Systems and Anticancer Drugs
by: Temidayo O. B. Olusanya, et al.
Published: (2018-04-01)

Role of Reductive versus Oxidative Stress in Tumor Progression and Anticancer Drug Resistance
by: Kyung-Soo Chun, et al.
Published: (2021-03-01)

Primary cilia: a novel research approach to overcome anticancer drug resistance
by: Kyung Ho Lee, et al.
Published: (2023-10-01)